Back to Search
WILLIAM TESTER, MD
MD
Hematology & Oncology Physician
NPI: 1386613693IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology Physician
Internal Medicine — Medical Oncology
Code: 207RX0202X
MD021791E(PA)
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
MD021791E(PA)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
HAHNEMANN UNIVERSITY COLLEGE OF MEDICINE
Class of 1972
Research & Publications (12)
Innovative treatments for non-small cell lung cancer.
PMID 11772232·Expert Opin Investig Drugs·2001
6-review
The importance of patient participation in second-line chemotherapy decisions: perspectives of African-American patients.
PMID 19110911·J Natl Med Assoc·2008
8-other
Comparison of outcomes for elderly patients treated with weekly paclitaxel in combination with carboplatin versus the standard 3-weekly paclitaxel and carboplatin for advanced nonsmall cell lung cancer.
PMID 18512224·Cancer·2008
3-trial
Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for patients with previously untreated advanced non-small-cell lung cancer.
PMID 18202422·J Clin Oncol·2008
3-trial
Randomized phase II trial of paclitaxel plus carboplatin or gemcitabine plus cisplatin in Eastern Cooperative Oncology Group performance status 2 non-small-cell lung cancer patients: ECOG 1599.
PMID 17264337·J Clin Oncol·2007
3-trial
Infradiaphragmatic versus supradiaphragmatic Hodgkin lymphoma: a retrospective review of 1,114 patients.
PMID 16263573·Leuk Lymphoma·2005
8-other
Treatment preferences and advance care planning at end of life: the role of ethnicity and spiritual coping in cancer patients.
PMID 16173914·Ann Behav Med·2005
3-trial
Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: a report from the Radiation Therapy Oncology Group.
PMID 15890569·Int J Radiat Oncol Biol Phys·2005
8-other
Who enrolls in observational end of life research? Report from the cultural variations in approaches to end of life study.
PMID 15662180·J Palliat Med·2005
8-other
Family care giving for patients at life's end: report from the cultural variations study (CVAS).
PMID 16594278·Palliat Support Care·2003
8-other
Approaching the end of life: attitudes, preferences, and behaviors of African-American and white patients and their family caregivers.
PMID 12560448·J Clin Oncol·2003
4-observational
Overview of bladder cancer trials in the Radiation Therapy Oncology Group.
PMID 12673704·Cancer·2003
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 925 CHESTNUT ST STE 320A
PHILADELPHIA, PA 19107 - Phone
- (215) 955-8874
Quick Facts
- NPI
- 1386613693
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 54
- Publications
- 12
Are you this provider?
Claim Your Profile